Rigel Pharmaceuticals (RIGL) Other Non-Current Liabilities (2010 - 2025)
Rigel Pharmaceuticals (RIGL) reported Other Non-Current Liabilities of $5 million for Q3 2025, unchanged from $5 million a year earlier and unchanged from the prior quarter.
Rigel Pharmaceuticals (RIGL) Other Non-Current Liabilities (2010 - 2025) Analysis & Trends
At the end of FY2024, Rigel Pharmaceuticals posted Other Non-Current Liabilities of $39.98 million, up 0.1% from FY2023.
- Other Non-Current Liabilities has a five-year compound annual growth rate of 51.0% (FY2019 to FY2024).
- By year, Other Non-Current Liabilities came in at $39.94 million in FY2023 (-5.5%), $42.26 million in FY2022 (-19.8%), $52.73 million in FY2021 (+945.1%) and $5.05 million in FY2020 (-1.0%).
- Five-year quarterly Other Non-Current Liabilities spans a low of $5 million in Q3 2024 and a high of $57.53 million in Q1 2021.
- Year over year, Other Non-Current Liabilities gained in two of the last eight quarters, with an average decline of 15.5%.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q3 2021 (growth of 987.3%); the low point was Q3 2024 (a decline of 87.1%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $5 million (Q2 2025), $39.98 million (Q1 2025) and $39.98 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Rigel Pharmaceuticals | 801.35 Mn | 305.08 Mn | 70.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 49.98 Mn |
| Dec 31, 2024 | 44.98 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 15.22 Mn |
| Dec 31, 2023 | 39.94 Mn |
| Sep 30, 2023 | 38.76 Mn |
| Jun 30, 2023 | 40.98 Mn |
| Mar 31, 2023 | 42.07 Mn |
| Dec 31, 2022 | 42.26 Mn |
| Sep 30, 2022 | 48.71 Mn |
| Jun 30, 2022 | 46.89 Mn |
| Mar 31, 2022 | 53.20 Mn |
| Dec 31, 2021 | 52.73 Mn |
| Sep 30, 2021 | 54.37 Mn |
| Jun 30, 2021 | 48.23 Mn |
| Mar 31, 2021 | 57.53 Mn |
| Dec 31, 2020 | 5.05 Mn |
Rigel Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RIGL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();